Katie Dahlstrom
Director Técnico/Científico/I+D en THESEUS PHARMACEUTICALS, INC. .
Perfil
Katie Dahlstrom is currently the Vice President-Clinical Development Operations at Theseus Pharmaceuticals, Inc. Previously, she worked as the Senior Director-Clinical Operations at Agios Pharmaceuticals, Inc. She completed her undergraduate degree at Stonehill College, Inc. and her graduate degree at Boston University School of Medicine.
Cargos activos de Katie Dahlstrom
| Empresas | Cargo | Inicio |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Katie Dahlstrom.
| Empresas | Cargo | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Formación de Katie Dahlstrom.
| Stonehill College, Inc. | Undergraduate Degree |
| Boston University School of Medicine | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Katie Dahlstrom
